Related Experiment Video
Updated: May 16, 2026
07:05
Visualization of Neutrophil Extracellular Traps in Mesenteric Venules After Mesenteric Ischemia-Reperfusion Injury via Intravital Microscopy
Published on: September 27, 2024
Thrombomodulin in sepsis
1Department of Vascular Medicine and Internal Medicine, Academic Medical Center, University of Amsterdam, The Netherlands. m.m.levi@amc.uva.nl
Minerva Anestesiologica
|December 18, 2012
Summary
Thrombomodulin (TM) downregulation in sepsis impairs protein C activation, worsening coagulation and inflammation. Soluble TM administration shows promise in preclinical and early clinical studies for sepsis-associated complications.
Area of Science:
- Biochemistry
- Immunology
- Critical Care Medicine
Background:
- Thrombomodulin (TM) is crucial for the protein C system, regulating coagulation and inflammation.
- Sepsis leads to decreased endothelial TM expression, impairing protein C activation and exacerbating disease.
- TM possesses intrinsic immunomodulatory properties affecting neutrophils, complement, and cytokines.
Purpose of the Study:
- To evaluate the therapeutic potential of soluble thrombomodulin in sepsis.
- To investigate TM's role in modulating coagulation and inflammatory responses during sepsis.
Main Methods:
- Preclinical studies in experimental sepsis models.
- Analysis of initial clinical trials involving patients with disseminated intravascular coagulation, including sepsis patients.
Main Results:
- Soluble TM administration improved coagulation abnormalities in sepsis models.
- Treatment with soluble TM ameliorated inflammatory responses and restored organ function in preclinical studies.
- Early clinical data suggest recombinant soluble TM benefits coagulation and organ failure in patients with disseminated intravascular coagulation and sepsis.
Conclusions:
- Downregulation of thrombomodulin is a key factor in sepsis pathogenesis.
- Soluble thrombomodulin represents a potential therapeutic strategy for sepsis and its complications.
- Further clinical investigation of soluble TM in sepsis is warranted.
Related Concept Videos
01:25Acute Inflammation III: Local and Systemic Effects
Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...